Can You Scale It? Timely article today from BioSpace on the growing focus on manufacturing scalability and ramp-up. From early-stage biotech to big pharma, the push to scale manufacturing is driving some big conversations. Balancing growth, managing investments, and overcoming operational hurdles is a tough needle to thread—and competition for facilities that can meet these complex needs is only adding to the challenge. It’s been interesting to see how these pressures are reshaping real estate decisions across the sector. Finding spaces within talent rich markets that not only meet today’s demands but also allow for future growth is no small task. As we head into 2025, I’d love to hear how others are approaching these challenges. Article Link In Comments: (Biopharma’s Big Question of 2024: Can You Scale It?) #Biopharma #Manufacturing #CDMO #JPM2025
Taylor Caparosa’s Post
More Relevant Posts
-
The drug development and manufacturing process can be daunting. There’s no perfectly templated guide that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. But we’re here to help identify the building blocks – the framework, scale-up, and manufacturing – that naturally come next. We’ve designed a tool to help your team and ours can use to quickly identify which steps in the drug substance manufacturing process might be most effectively accomplished through a partnership. Take the questionnaire today to learn how Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02qft400 #DrugSubstanceManufacturing #SproutSolutions #CDMO
-
-
The drug development and manufacturing process can be daunting. There’s no perfectly templated guide that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. But we’re here to help identify the building blocks – the framework, scale-up, and manufacturing – that naturally come next. We’ve designed a tool to help your team and ours can use to quickly identify which steps in the drug substance manufacturing process might be most effectively accomplished through a partnership. Take the questionnaire today to learn how Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02qfxBz0 #DrugSubstanceManufacturing #SproutSolutions #CDMO
-
-
The drug development and manufacturing process can be daunting. There’s no perfectly templated guide that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. But we’re here to help identify the building blocks – the framework, scale-up, and manufacturing – that naturally come next. We’ve designed a tool to help your team and ours can use to quickly identify which steps in the drug substance manufacturing process might be most effectively accomplished through a partnership. Take the questionnaire today to learn how Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02qfwcN0 #DrugSubstanceManufacturing #SproutSolutions #CDMO
-
-
The drug development and manufacturing process can be daunting. There’s no perfectly templated guide that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. But we’re here to help identify the building blocks – the framework, scale-up, and manufacturing – that naturally come next. We’ve designed a tool to help your team and ours can use to quickly identify which steps in the drug substance manufacturing process might be most effectively accomplished through a partnership. Take the questionnaire today to learn how Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02rYnkq0 #DrugSubstanceManufacturing #SproutSolutions #CDMO
-
-
The drug development and manufacturing process can be daunting. There’s no perfectly templated guide that demonstrates the step-by-step route of getting your product to the market, because your innovation is unique and blazing its own trail. But we’re here to help identify the building blocks – the framework, scale-up, and manufacturing – that naturally come next. We’ve designed a tool to help your team and ours can use to quickly identify which steps in the drug substance manufacturing process might be most effectively accomplished through a partnership. Take the questionnaire today to learn how Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02qfF4p0 #DrugSubstanceManufacturing #SproutSolutions #CDMO
-
-
Investment Professional with Global Leadership Roles Across Private Equity, Hedge Funds, and Asset Management
I agree with my colleague Lisa. EY's Deal Barometer expects M&A activity to rise by 10% in 2025 and for private equity, a 16% increase. Some sectors are likely to see more than others given their unique dynamics. https://lnkd.in/eFKaAgjT #PrivateEquity #PE #deals
With the cost of capital coming down and the need for pharma pipeline replenishment remaining ever-present, the life sciences dealmaking environment is due to pick up in 2025. If this trend around reduced interest rates continues, 2025 could bring megadeals for companies that are still seeking to fill the growth gap ahead of the large loss-of-exclusivity event in 2028, although most deals will likely continue to be the smaller, more strategic plays that we’ve seen in 2024. https://lnkd.in/e-JgeQMY
-
People and Digitalization are synonymous in how we tackle process optimization. Please listen to a short conversation on this topic from my colleague Jose Castaneda. For future discussion, please reach out. #people #digitilization#pharmamanunfacturing#smartfactoryrx
🎧 Listen to the first in our series of short conversations on Pharma 4.0 with José Fidel Castañeda - How does it work in the real world? 🏭 Digitization or digitalization? People or processes? #Pharma4 #SmartFactoryRx #Pharmamanufacturing #bioprocessing
-
Founder @ Ajay Techma Systems | with Passion for Achieving Business Excellence by Adoption of Technology and Digital Transformation
Building a Smart Manufacturing Ecosystem in pharma requires a Deliberate Approach, focusing on key Building Blocks that Synergistically create an Efficient, Innovative, and Patient-centric environment. Some essential pillars to consider are discussed here.
Smart Manufacturing Building Blocks for Pharma Part 1
https://www.youtube.com/
-
ARTICLE – The future of #pharma is being reshaped through collaboration and cutting-edge technology. Experts from Bristol Myers Squibb, Emerson's Automation Technologies & Solutions and FUJIFILM Diosynth Biotechnologies share the role that each of the companies play in shortening the time it takes to get drugs to market faster. The impact of trust and technology, changes in manufacturing to accelerate time to market, and automation at the core are a few topics discussed in this article. Read the full article in Pharma Manufacturing https://ow.ly/nGSw30sGp8L #software #analytics
Accelerating the pharma pipeline is a shared journey
pharmamanufacturing.com
Commercial Real Estate Advisor, Life Sciences
1whttps://www.biospace.com/business/biopharmas-big-question-of-2024-can-you-scale-it?utm_campaign=Newsletter%20%7C%20BioPharm&utm_medium=email&_hsenc=p2ANqtz-_XL_aBP5-QW9L-Vpsya2rZ7RRsaDal-khRDdH0pqH-1FGe_A-ILhXYMzR8OeB7Huw1nSqj5ddS47HG_7VYH8qacZAH5A&_hsmi=339168968&utm_content=339168968&utm_source=hs_email